# Setmelanotide for hypothalamic obesity: 16-week BMI results

Source: https://pepvault.app/research/setmelanotide-roth-2024

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Setmelanotide](https://pepvault.app/research#setmelanotide)

Clinical trial · people

# Setmelanotide: 15% mean BMI drop at 16 weeks in hypothalamic obesity

Checked against the paper November 2026 Clinical trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In a small, uncontrolled trial, setmelanotide lowered BMI and hunger in people whose obesity followed hypothalamic damage, and nausea and skin darkening were common.

- **Kind:** Clinical trial
- **Studied in:** People
- **Number studied:** 18
- **Published:** 2024
- **Journal:** Lancet Diabetes Endocrinol

## What they tested

The team tested whether daily setmelanotide could lower body mass index in people whose obesity followed damage to the hypothalamus, a part of the brain.

## How the study was done

A phase 2, open-label trial at 5 US centers in 18 patients aged 6 to 40 years with obesity after a hypothalamic injury or a treated non-cancerous tumor in that area. Everyone got daily setmelanotide shots under the skin, raised up to 3.0 mg, for 16 weeks, with no placebo group. Results were compared with a historic rate of under 5% reaching the goal in this group.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

16 of 18 patients (89%) finished the trial and lowered their BMI (body mass index, a measure of weight for height) by at least 5%. Mean BMI fell by 15% (SD 10). Among patients aged 12 or older, hunger scores fell by a mean 45%. Common side effects were nausea (61%), vomiting (33%), skin darkening (33%) and diarrhea (22%). In a follow-on study, 12 patients treated for at least 12 months had a mean BMI change of -26% (SD 12) from the start.

## What it doesn’t show

This was a small, 16-week trial with no placebo group, and everyone knew they were getting the drug, so results were judged against a historic rate rather than a direct comparison group. It was funded by Rhythm Pharmaceuticals.

## The paper

Roth et al. Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial. Lancet Diabetes Endocrinol. 2024.

- [PubMed (PMID 38697184)](https://pubmed.ncbi.nlm.nih.gov/38697184/)
- [The paper (DOI 10.1016/S2213-8587(24)00087-1)](https://doi.org/10.1016/S2213-8587%2824%2900087-1)
- [ClinicalTrials.gov (NCT04725240)](https://clinicaltrials.gov/study/NCT04725240)

## The compound

- [Setmelanotide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

## With this study

### Setmelanotide

- [Setmelanotide: the full reference](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

### Studies

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026)
- [Setmelanotide: 16.5% BMI drop at 52 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-transcend-2026)
- [Setmelanotide: patients reported less hunger, more energy in TRANSCEND](https://pepvault.app/research/setmelanotide-transcend-2026-42528856)
- [All 8 studies](https://pepvault.app/research#setmelanotide)

### Compared with

- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)
- [Melanotan II vs Setmelanotide](https://pepvault.app/peptides/compare/melanotan-ii-vs-setmelanotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Open-label](https://pepvault.app/glossary/open-label)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

## More studies on Setmelanotide

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026) Meta-analysis · people · 2026
- [Setmelanotide: 16.5% BMI drop at 52 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-transcend-2026) Randomized trial · people · 2026
- [Setmelanotide: patients reported less hunger, more energy in TRANSCEND](https://pepvault.app/research/setmelanotide-transcend-2026-42528856) Clinical trial · people · 2026
- [Setmelanotide: mean BMI fell 18% at 52 weeks in ages 2-5 (VENTURE)](https://pepvault.app/research/setmelanotide-venture-2025) Clinical trial · people · 2025
- [Setmelanotide: quality of life rose after 52 weeks in Bardet-Biedl](https://pepvault.app/research/setmelanotide-forsythe-2023) Clinical trial · people · 2023
- [Setmelanotide: 80% (POMC) and 45% (LEPR) lost at least 10% weight](https://pepvault.app/research/setmelanotide-clement-2020) Clinical trial · people · 2020
- [Every study on Setmelanotide](https://pepvault.app/research#setmelanotide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Setmelanotide

- [Setmelanotide: the full reference](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

### Studies

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026)
- [Setmelanotide: 16.5% BMI drop at 52 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-transcend-2026)
- [Setmelanotide: patients reported less hunger, more energy in TRANSCEND](https://pepvault.app/research/setmelanotide-transcend-2026-42528856)
- [All 8 studies](https://pepvault.app/research#setmelanotide)

### Compared with

- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)
- [Melanotan II vs Setmelanotide](https://pepvault.app/peptides/compare/melanotan-ii-vs-setmelanotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Open-label](https://pepvault.app/glossary/open-label)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)

<!--promo-->

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Setmelanotide](https://pepvault.app/research#setmelanotide)

## The library

- [Setmelanotide](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
